Progress, Potential, and Possibilities Podcast / Show · 2026-05-14 · 48 min
Send us Fan Mail Psychedelic medicine is no longer fringe science - it’s now part of White House policy discussions, FDA fast-track programs, and a rapidly emerging neuropsychiatric industry. But can these therapies truly become scalable standards of care? Eric So is Co-Founder and Executive Chairman of Helus Pharma ( ), a company focused on developing next-generation serotonergic therapies for mental illness and advancing the broader field of psychedelic-assisted psychiatry. With a multidisciplinary background spanning science, law, finance, and entrepreneurship, Eric has spent his career building and scaling public and private companies across emerging sectors. Before launching Helus Pharma in 2019, Eric was involved with a number of high-growth ventures, including leadership roles at Globalive Technology and Therapix Biosciences Ltd., where he gained firsthand experience navigating the intersection of biotechnology innovation, regulation, and capital markets. He earned a Bachelor of Science in Cell Biology and Anatomy from McGill University before obtaining his law degree from University of Windsor.
Other episodes covering the same guests and topics, from across The B2B Podcast Index.
101: Rapid Transformation - AI, Psychedelics & Leadership with Dr Catriona WallaceHabits of Leadership · on Psychedelics73 / 100
Ep 216, Failure Is A Component Of SuccessConflict Managed · on neuroscience69 / 100
077 Gabe Derita: Neuroscience & IkigaiUnbound with Chris DuBois · on neuroscience64 / 100
Ep 201: The Leadership School Hidden Inside the Black ChurchThe Culture Soup Podcast®️ · on neuroscience63 / 100
Emotionally Intelligent Innovation: Transforming Customer Experiences with Craig TuckerScience of CX · on neuroscience61 / 100
THE #1 THING HOLDING YOU AND YOUR COMPANY BACK AND HOW TO FIX ITB2B Revenue Leadership · on neuroscience44 / 100Building the Internet of Medicine: How AI Could Transform Children's Healthcare | Dr. Timothy Chou - Founder, Pediatric Moonshot92 / 100The Blood Test That Could Change Cancer Treatment Forever | Eric Matthews - General Manager, Biopharma, Natera65 / 100How Female Biology Shapes Skin Disease Across a Lifetime | Dr. Doral Fredericks, PharmD, MBA - Vice President and Head of Global Medical Affairs and Outcomes Research, Organon56 / 10055 Years Without a Diagnosis | Can AI Solve The Undiagnosed Condition Blind Spot? | Haresh Patel - Founder and CEO, Sanare Health AI70 / 100How Regenerative Medicine Is Reinventing Breast Reconstruction | Dr. Claudia Chavez-Munoz, MD, PhD - Chief Scientific Officer and Co-Founder - Conexeu Sciences